Compare Lustrum:Fuji Pharma Co.,Ltd.:4554

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Fuji Pharma Co.,Ltd. Go to web site 4554 Medicals 東証プライム September 1, 2000 1995.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Fuji Pharma Co.,Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Fuji Pharma Co.,Ltd. Balance Sheet 2023年9月期 Fuji Pharma Co.,Ltd. Balance Sheet 2022年9月期 Fuji Pharma Co.,Ltd. Balance Sheet 2021年9月期 Fuji Pharma Co.,Ltd. Balance Sheet 2020年9月期 Fuji Pharma Co.,Ltd. Balance Sheet 2019年9月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date September 30, 2023 September 30, 2022 September 30, 2021 September 30, 2020 September 30, 2019
Cash and Cash Equivalents
(Percent)
2,324down
(2.7%)down
3,546down
(4.7%)down
10,199down
(15.9%)down
12,041up
(19.4%)up
8,494
(14.0%)
Other Current AssetsHelp
(Percent)
36,790up
(43.1%)up
31,181up
(41.3%)up
24,635up
(38.3%)up
22,934down
(37.0%)down
25,425
(41.9%)
Tangible Fixed AssetsHelp
(Percent)
20,547up
(24.1%)down
18,762up
(24.8%)up
14,392up
(22.4%)up
12,767up
(20.6%)up
11,718
(19.3%)
Intangible Fixed AssetHelp
(Percent)
738up
(0.9%)down
660down
(0.9%)down
1,532down
(2.4%)down
1,755down
(2.8%)down
1,806
(3.0%)
Investments and OthersHelp
(Percent)
15,178up
(17.8%)up
11,645down
(15.4%)down
12,616up
(19.6%)up
11,321down
(18.3%)down
11,800
(19.4%)
Total AssetsHelp
(Percent)
85,332
(100%)
75,538
(100%)
64,239
(100%)
61,962
(100%)
60,737
(100%)
Total Current LiabilitiesHelp
(Percent)
32,119up
(37.6%)up
26,282up
(34.8%)down
22,418up
(34.9%)up
12,969down
(20.9%)down
13,832
(22.8%)
Total Long-term LiabilitiesHelp
(Percent)
12,038down
(14.1%)down
13,452up
(17.8%)up
9,141up
(14.2%)down
9,034up
(14.6%)up
7,544
(12.4%)
Shareholder's EquityHelp
(Percent)
41,175up
(48.3%)up
35,804up
(47.4%)down
32,680down
(50.9%)down
39,959up
(64.5%)down
39,361
(64.8%)
Total LiabilitiesHelp
(Percent)
85,332
(100%)
75,538
(100%)
64,239
(100%)
61,962
(100%)
60,737
(100%)

Fuji Pharma Co.,Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Fuji Pharma Co.,Ltd. Profit and Loss Account 2023年9月期 Fuji Pharma Co.,Ltd. Profit and Loss Account 2022年9月期 Fuji Pharma Co.,Ltd. Profit and Loss Account 2021年9月期 Fuji Pharma Co.,Ltd. Profit and Loss Account 2020年9月期 Fuji Pharma Co.,Ltd. Profit and Loss Account 2019年9月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date September 30, 2023 September 30, 2022 September 30, 2021 September 30, 2020 September 30, 2019
Amount of Sales
(Percent)
40,889
(100%)
35,426
(100%)
33,990
(100%)
33,793
(100%)
36,279
(100%)
Total Sales
(Percent)
40,889
(100%)
35,426
(100%)
33,990
(100%)
33,793
(100%)
36,279
(100%)
Cost of SalesHelp
(Percent)
24,374up
(59.6%)up
20,867up
(58.9%)up
19,239up
(56.6%)up
18,921down
(56.0%)down
20,483
(56.5%)
Other Costs and RevenueHelp 13,079up
(32.0%)down
11,862down
(33.5%)down
12,318down
(36.2%)down
12,786down
(37.8%)up
12,833
(35.4%)
Total CostsHelp 37,453 32,729 31,557 31,707 33,316
Net RevenueHelp 16,515up
(40.4%)down
14,559down
(41.1%)down
14,751down
(43.4%)down
14,872down
(44.0%)up
15,796
(43.5%)
Earnings Before TaxHelp 4,399up
(10.8%)up
3,723up
(10.5%)up
3,371up
(9.9%)up
2,918down
(8.6%)down
3,961
(10.9%)
Net IncomeHelp 3,436up
(8.4%)up
2,697up
(7.6%)up
2,433up
(7.2%)up
2,086down
(6.2%)down
2,963
(8.2%)
当期純利益 3,436 2,697 2,433 2,086 2,963

Fuji Pharma Co.,Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Fuji Pharma Co.,Ltd. Cash Flow Statement 2023年9月期 Fuji Pharma Co.,Ltd. Cash Flow Statement 2022年9月期 Fuji Pharma Co.,Ltd. Cash Flow Statement 2021年9月期 Fuji Pharma Co.,Ltd. Cash Flow Statement 2020年9月期 Fuji Pharma Co.,Ltd. Cash Flow Statement 2019年9月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date September 30, 2023 September 30, 2022 September 30, 2021 September 30, 2020 September 30, 2019
Operating Cash Flow(OFC)Help
(Percent)
1,919up
(36.6%)up
-659down
(-5.5%)down
5,993up
(76.5%)down
5,769down
(92.8%)up
7,034
(49.2%)
Investing Cash Flow(ICF)Help
(Percent)
-5,240up
(-100.0%)down
-11,271down
(-94.5%)down
-2,345up
(-29.9%)up
-2,616up
(-42.1%)up
-12,024
(-84.1%)
Financing Cash FlowHelp
(Percent)
1,915down
(36.5%)down
5,094up
(42.7%)up
-5,435down
(-69.4%)down
450down
(7.2%)down
7,265
(50.8%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
185up
(3.5%)up
183up
(1.5%)up
-55up
(-0.7%)up
-56down
(-0.9%)down
-32
(-0.2%)
Net Increase and Decrease in Cash and Cash Equivalentsn -1,221up
(-23.3%)up
-6,653down
(-55.8%)down
-1,842down
(-23.5%)down
3,547up
(57.0%)up
2,243
(15.7%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Fuji Pharma Co.,Ltd.

Company where related level is highHelp

Daito Pharmaceutical Co.,Ltd.
Immuno-Biological Laboratories Co., Ltd.
Cuorips Inc.
RIBOMIC Inc.
MIZUHO MEDY CO.,LTD.
MORISHITA JINTAN CO.,LTD.
RaQualia Pharma Inc.
SanBio Company Limited
Nichi-Iko Pharmaceutical Co.,Ltd.
Mochida Pharmaceutical Co.,Ltd.